Pharmaceuticals

BD Alaris Systems Lawsuits

Morcellator LawsuitsThe BD Alaris System is used to observe a patient’s vital signs and deliver medications or fluids. BD Alaris pumps, manufactured by Becton, Dickinson and Company (BD), have been recalled four times alone this year due to defects that may pose the risks of death or serious injury. The Food and Drug Administration (FDA) has designated some of these recalls as Class I recalls- the most serious action taken by the Administration.
 

BD Alaris Systems Lawyers are Ready to Help

Contact our BD Alaris System Lawyers to review whether you or a family member may be entitled to financial compensation. Levy Konigsberg LLP is currently accepting BD Alaris System cases in all 50 states.

If you or a loved one has suffered one or more of these complications, you may be entitled to a cash award and compensation for medical expenses. For a free confidential consultation with BD Alaris System Lawyers at our law firm, please call 1-800-988-8005 or submit an email inquiry above.
 

What are BD Alaris Systems?

BD Alaris is a series of infusion and IV systems that administer medications and fluids to patients in controlled doses. The BD Alaris system contains a PCU (point of care unit) with four potential modules to program the device to deliver a specified amount of medication. The modules include the Alaris Syringe Module, BD Pump Module, Alaris EtCO2 Module, and Alaris Auto-ID Module. These infusion systems can be used for adult, pediatric and neonatal patients. BD Alaris products were initially approved by the FDA in 1995.
 

What is Happening with BD Alaris Systems?

The BD Alaris system has been recalled several times in the last few years. In 2020 alone, the company issued four separate recalls of more than one million devices. The following systems and model numbers were subject to the latest recalls: the Alaris System Infusion Pumps, the Alaris PC Unit Model 8015, BD Alaris Syringe Module, and the BD Alaris PCA Module.

The FDA’s recall of BD Alaris system models were mostly classified as Class I recalls, thereby warning the public that BD Alaris products could lead to severe injury or death. The agency determined that the defective devices include damaged interfaces, broken elements on the pump mechanism, improper attachment of the battery, faulty module display, software errors, low battery alarm failures, options programming irregularities and other use errors.  The device’s failure to function properly may lead to delayed, interrupted or improper infusion of medications and fluids.

https://www.fda.gov/medical-devices/medical-device-recalls/becton-dickinson-bd-carefusion-303-inc-recalls-alaris-system-infusion-pumps-due-software-and-system
 

BD Alaris System Side Effects and Complications

Complications of BD Alaris Systems that may lead to serious injury or death include:

  • Delayed infusion;
  • Interruption of infusion;
  • Slower delivery; and
  • Faster delivery.

 

BD Alaris System Lawyers are Ready to Help

Contact our BD Alaris System Lawyers to review whether you or a family member may be entitled to financial compensation. Levy Konigsberg LLP is currently accepting BD Alaris System cases in all 50 states.

If you or a loved one has suffered one or more of these complications, you may be entitled to a cash award and compensation for medical expenses. For a free confidential consultation with BD Alaris System Lawyers at our law firm, please call 1-800-988-8005 or submit an email inquiry above.

For more information about the law firm's practice areas please contact Levy Konigsberg LLP at 1-212-605-6200 or 1-800-988-8005, 24 hours a day, 7 days a week.

Do You Have a Case?
Find Out Now.

National Offices

New York

605 Third Avenue, 33rd Floor
New York, New York 10158
Telephone: 212-605-6200

New Jersey

101 Grovers Mill Rd, Ste 105
Lawrence Twp, NJ 08648
Telephone: 609-720-0400

Serving Clients Nationwide


Telephone: 800.988.8005

         
Google Rating
4.8
Based on 44 reviews
Attorney Advertising: Prior results do not guarantee a similar future outcome.